Publications by authors named "Elizabeth Westerhaus"

Background: Integrase inhibitors (INSTIs) have been associated with poorer cognition in people with HIV (PWH). We examined the impact of switching to INSTIs on neuropsychological (NP) outcomes in PWH 40 years of age and older.

Methods: From the AIDS Clinical Trials Group observational cohort study, HAILO, we identified PWH who switched to INSTIs, had ≥2 NP assessments before and at least 1 after switch, and maintained viral suppression while on INSTIs.

View Article and Find Full Text PDF
Article Synopsis
  • Despite the benefits of antiretroviral therapy (ART) for individuals with HIV, issues with brain function and inflammation persist, impacting health outcomes.
  • A study involving 173 individuals with HIV on ART found that lower CD4/CD8 T-cell ratios and higher inflammatory markers (CD16+ monocytes and soluble CD14) are linked to reduced brain volume and altered blood flow in various brain regions.
  • The research suggests that chronic immune system changes can lead to brain structural issues, indicating a need for further investigation into these relationships and their implications for cognitive health in people with HIV.
View Article and Find Full Text PDF

Background: With the advent of antiretrovirals, people living with HIV are living near-normal lifespans. However, people living with HIV are at greater risk of experiencing cognitive impairment and reduced brain integrity despite well-controlled viremia. A robust literature supports exercise interventions as a method of improving cognition and structural brain integrity in older individuals without HIV.

View Article and Find Full Text PDF

Background: Persons with HIV (PWH) are at increased risk of frailty, a clinically recognizable state of increased vulnerability resulting from aging-associated decline in multiple physiologic systems. Frailty is often defined by the Fried criteria, which includes subjective and objective standards concerning health resiliency. However, these frailty metrics do not incorporate cognitive performance or neuroimaging measures.

View Article and Find Full Text PDF

Introduction: Progression to symptomatic Alzheimer disease (AD) occurs slowly over a series of preclinical stages. Declining functional mobility may be an early indicator of loss of brain network integration and may lead to an increased risk of experiencing falls. It is unknown whether measures of functional mobility and falls are preclinical markers of AD.

View Article and Find Full Text PDF

Inflammation occurs after HIV infection and persists, despite highly active antiretroviral therapy (HAART). Diffusion tensor imaging (DTI) measures HIV-associated white matter changes, but can be confounded by inflammation. Currently, the influence of inflammation on white matter integrity in well-controlled HIV+ patients remains unknown.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted on brain volume changes in HIV-infected and uninfected participants using a data-driven approach to minimize bias, analyzing the impacts of aging, viral factors, antiretroviral therapy, gender, and smoking.
  • The research involved 51 HIV-uninfected participants and 146 HIV-infected participants, using structural MRI and principal component analysis (PCA) to identify volumetric changes and their associations with cognitive function.
  • Findings revealed significant age-related volumetric changes in cortical regions due to HIV and smoking, with correlations between cortical volume and cognitive scores in HIV+ patients linked to their immune history, while subcortical changes associated with current viral load.
View Article and Find Full Text PDF

HIV causes neural dysfunction in infected individuals. This dysfunction often manifests as cognitive symptoms and can be detected using neuroimaging. Highly active anti-retroviral therapy (HAART), in addition to providing virologic control, has reduced the number of profoundly impaired individuals but more mild forms of neurocognitive disorders remains prevalent.

View Article and Find Full Text PDF

Previous studies have identified cognitive impairments due to human immunodeficiency virus (HIV) in adults. However, few studies have examined the impact of HIV on cognition in young adults (18-24 years old). Yet, this group is one of the largest populations of individuals with new HIV infection.

View Article and Find Full Text PDF

The diagnosis of human immunodeficiency virus (HIV)-associated neurocognitive impairment is time-intensive and often omitted in busy outpatient settings. Brief screening tools are needed. The Montreal Cognitive Assessment (MoCA) and the Alzheimer's disease (AD)-8 have been used in neurodegenerative disorders.

View Article and Find Full Text PDF

Little systematic information is available on mental health issues related to bioterrorism. Five focus groups were conducted with Capitol Hill office staff (n = 28 total participants) to learn about their experience of the anthrax incident on October 15, 2001. More than 2,000 verbal passages were coded into categories and themes by using qualitative analysis software.

View Article and Find Full Text PDF

Systematic studies of mental health effects of bioterrorism on exposed populations have not been carried out. Exploratory focus groups were conducted with an exposed population to provide qualitative data and inform empirical research. Five focus groups of 28 political worker volunteers were conducted 3 months after the October 15, 2001, anthrax attack on Capitol Hill.

View Article and Find Full Text PDF